Investor case

Investor information for AD-01 sovereign attritable autonomy.

Austera's investment case is built around a tightly sequenced build-and-fly program: prove AD-01 repeatable flight and pilot readiness, then extend the common stack into AD-02 counter-FPV defence, mission software, simulation and low-rate production readiness.

AD-Fleet operational dashboard and support workspace representing low-rate readiness

Investor figures are management planning assumptions until validated by supplier quotes, flight data, partner agreements, customer commitments and approval pathways.

Investor information on this page summarizes the supplied business case. It is not financial advice and should be read as planning material subject to diligence, validation and change.

A$1.5MPre-seed funding ask.
24 moTarget path to low-rate readiness.
G0-G5AD-01 risk-retirement milestones.
4-6Small technical core plus specialists.
What is built first

AD-01, the sovereign attritable platform.

A low-cost fixed-wing unmanned aircraft, common autonomy core, mission interface, simulation environment and support package built to reach repeatable flight and pilot readiness.

Why financeable

Early revenue can come through evaluation, training and support work.

Buyers and partners can engage around recoverable or inert evaluation, range targets, mission modelling, software, simulation, counter-FPV training and support tooling while higher-consequence pathways mature.

Why venture-scale

The durable asset is the common autonomy stack.

AD-01 creates flight data and production learning; AD-02, mission software, simulation, support tooling and partner pathways can expand from the same controlled core.

Gated roadmap

Retire AD-01 risk in the correct order.

Each gate ends with an evidence package and a capital decision. AD-02 and derivative expansion do not move ahead of AD-01 proof.

0G0 Architecture freeze
1G1 Bench and subsystem proof
2G2 First controlled flight
3G3 Repeatable flight
4G4 Pilot-ready system
5G5 Low-rate readiness
Use of funds

The first capital buys AD-01 evidence, not overhead.

The round is sized to reach repeatable flight, pilot readiness and low-rate cell preparation without assuming a speculative follow-on before the product is credible.

Use of fundsA$m%Purpose
Engineering and prototyping0.4530%Structures, integration, prototype builds and flight-test iteration.
Software, simulation and test infrastructure0.2215%Mission software, replay, telemetry, HIL and data tooling.
Flight test and operations0.1812%Range use, safety controls, travel and field equipment.
Tooling, jigs and low-rate cell0.2013%Assembly jigs, QA tooling and acceptance-test hardware.
Supply chain, inventory and spares0.1711%Long-lead items, pilot units and support stock.
Commercial, compliance and pilots0.1510%Pilot support, proposals, contracting and documentation.
Working capital reserve0.139%Schedule and supplier buffer.
Customer pathway

AD-01 defence evaluation

Flight trials, range targets, training configurations, mission modelling, support packages and evidence for ASCA/CASG-aligned pathways.

Customer pathway

AD-02 counter-FPV pathway

Counter-FPV training, detection and alerting workflows, defensive integration support and counter-small-UAS evidence packages.

Partner pathway

Prime and subsystem programs

Mission software, simulation, payload interfaces, telemetry replay and systems assurance as supplied components.

Risk controls

The mitigation is structural, not optimistic.

The business case keeps scope narrow: prove AD-01 first, package evidence, then expand into AD-02 and derivative missions through controlled interfaces.

Technical execution

AD-01 integration risk delays the roadmap.

Mitigation: narrow baseline, clear interfaces, configuration control and staged flight evidence.

Scope control

Too many variants fracture focus.

Mitigation: staged releases, defined product status and no payload proliferation before baseline stability.

Commercial adoption

Pilots do not convert fast enough.

Mitigation: range and training customers, AD-02 counter-FPV adjacency, partner channels, support attach and multiple conversion paths.

Investor contact

Discuss AD-01, AD-02, the round and the gated evidence plan.